Trends in Incidence and Survival of Patients With Thymic Epithelial Tumor in a High-Incidence Asian Country: Analysis of the Korean Central Cancer Registry 1999 to 2017

胸腺瘤 胸腺癌 医学 入射(几何) 内科学 癌症登记处 癌症 胃肠病学 肿瘤科 病理 光学 物理
作者
Dong Wook Shin,Jong Ho Cho,Johyun Ha,Kyu‐Won Jung
出处
期刊:Journal of Thoracic Oncology [Elsevier BV]
卷期号:17 (6): 827-837 被引量:19
标识
DOI:10.1016/j.jtho.2022.02.001
摘要

IntroductionTo report the trends in incidence and survival associated with thymic epithelial tumors (TETs) in Korea.MethodsData from 1999 to 2017 were obtained from the Korean Central Cancer Registry. Age-standardized incidence rates and average annual percentage changes (AAPCs) were calculated. Net survival (NS) was estimated by the Pohar-Perme method.ResultsAmong 5812 patients diagnosed with having TETs, 58.9%, 38.1%, and 3.0% were diagnosed with having thymoma, thymic carcinoma, and thymic neuroendocrine tumor (NET), respectively. Age-standardized incidence rates were 0.50, 0.30, 0.18, and 0.02 per 100,000 for all TETs and the respective subtypes. There was an increase in incidence of all TETs (AAPC = 6.1%) and subtypes: thymoma (AAPC = 5.6%), thymic carcinoma (AAPC = 7.0%), and thymic NET (AAPC = 3.4%). Proportions of patients with thymoma, thymic carcinoma, and thymic NET were 58.9%, 38.1%, and 3.0%, respectively. For thymoma, the relative proportion of distant stage decreased (19.4% in 2005 to 8.8% in 2017) and low-grade WHO subtype (A, AB, B1) increased faster than high-grade WHO type (B2, B3) (AAPC = 19.8% versus 9.6%). For thymoma, the 5-year NS was 82.3%. This increased from 64.3% in 1999 to 2002 to 90.6% in 2013 to 2017. For thymic carcinoma, the 5-year NS was 46.2% and only slightly increased from 39.4% in 1999 to 2002 to 47.9% in 2013 to 2017.ConclusionsThis study indicates a high incidence of TET and its continuous increase in Korea. The proportion of thymic carcinoma was relatively higher than in the United States or Europe. Survival for thymoma improved during the study period, whereas this was not evident for thymic carcinoma or thymic NET.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dream发布了新的文献求助10
1秒前
suering关注了科研通微信公众号
1秒前
Hello应助zhai采纳,获得10
2秒前
2秒前
似非发布了新的文献求助10
3秒前
摇不滚摇滚完成签到 ,获得积分10
3秒前
独特冰安发布了新的文献求助10
4秒前
内向万天完成签到,获得积分10
4秒前
6秒前
swy发布了新的文献求助10
6秒前
ldjekfj完成签到,获得积分10
6秒前
calico完成签到,获得积分10
6秒前
陈瑶完成签到,获得积分20
7秒前
常常发布了新的文献求助10
8秒前
magicjerry发布了新的文献求助10
9秒前
李治稳发布了新的文献求助10
9秒前
9秒前
lll完成签到,获得积分10
9秒前
李健的粉丝团团长应助swy采纳,获得10
9秒前
积极松鼠完成签到,获得积分10
10秒前
王1发布了新的文献求助10
11秒前
12秒前
爱科研的罗罗完成签到,获得积分10
12秒前
suering发布了新的文献求助50
13秒前
13秒前
猪猪hero应助wjx采纳,获得10
13秒前
失眠无声发布了新的文献求助10
15秒前
yyds完成签到,获得积分10
16秒前
,,,发布了新的文献求助10
16秒前
17秒前
17秒前
orixero应助an采纳,获得10
18秒前
18秒前
18秒前
共享精神应助王梦豪采纳,获得10
19秒前
20秒前
null完成签到,获得积分10
20秒前
21秒前
阳光的梦寒完成签到 ,获得积分10
21秒前
magicjerry完成签到,获得积分10
21秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975250
求助须知:如何正确求助?哪些是违规求助? 3519625
关于积分的说明 11199055
捐赠科研通 3255962
什么是DOI,文献DOI怎么找? 1798001
邀请新用户注册赠送积分活动 877358
科研通“疑难数据库(出版商)”最低求助积分说明 806298